Dr. Amol Matharu (MS in Industrial Pharmacy, ’98; PhD in Pharmaceutical Sciences, ’10) is the new Chief Scientific Officer at Aprecia Pharmaceuticals. Aprecia is the world’s first and only FDA-validated, commercial scale three-dimensional printing pharmaceutical manufacturer.
